Burning Rock Biotech (BNR) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Burning Rock Biotech Limited is set to delist its American Depositary Shares (ADSs) from the London Stock Exchange due to low trading volume and high maintenance costs, with an anticipated effect date around September 18, 2024. However, the company’s ADSs will remain available for trading on the Nasdaq Global Market. This move reflects Burning Rock’s strategic adjustments in response to market conditions while continuing their focus on next generation sequencing technology in precision oncology.
For further insights into BNR stock, check out TipRanks’ Stock Analysis page.
